Aravive Inc

NASDAQ:ARAV

2.30

+0.03 (+1.32%)

7:53:18 PM EDT: $2.29 -0.01 (-0.44%)

Market Cap (Intraday)	137.64M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.57 Million
Adjusted EPS	-$0.32

See more estimates

10-Day MA	$2.11
50-Day MA	$1.89
200-Day MA	$1.29

See more pivots

Aravive Inc Stock, NASDAQ:ARAV

River Oaks Tower, 3730 Kirby Drive, Houston, Texas 77098

United States of America

Phone: +1.936.355.1910

Number of Employees: 23

http://www.aravive.com

Description

Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.